NCT05253768 - Fecal Microbiota Transplantation (FMT) & Adiposity / obesity and Type 2 Diabetes (T2D)

Study overview

NCT05253768 - Fecal Microbiota Transplantation (FMT) & Adiposity / obesity and Type 2 Diabetes (T2D) is a randomized clinical phase II treatment trial to study Fecal Microbiota Transplantation (FMT) or placebo in patients with adiposity / obesity (24kg/m^2 ≤BMI≤ 35kg/m^2^) and Type 2 Diabetes (T2D)

Primary outcome measures

Percentage of change in weight compared with baseline

Results

Published results could not be found as of February 2026